Quantisnow Logo
Dashboard

SEC Form SC 13G/A filed by Barnes Group Inc. (Amendment)

$B
Metal Fabrications
Industrials
Get the next $B alert in real time by email
SC 13G/A 1 B_123122.txt CHAMPLAIN 13G TICKER B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ________)* Barnes Group, Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 067806109 (CUSIP Number) 12/31/2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: /X/ Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. 13G CUSIP No. 067806109 1. Names of Reporting Persons. Champlain Investment Partners, LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [ ] 3. SEC Use Only 4. Source of Funds (See Instructions) 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ] 6. Citizenship or Place of Organization Vermont Number of Shares Beneficially Owned by Each Reporting Person With: 7. Sole Voting Power 1738085 8. Shared Voting Power 9. Sole Dispositive Power 2282215 10. Shared Dispositive Power 11. Aggregate Amount Beneficially Owned by Each Reporting Person 2282215 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] 13. Percent of Class Represented by Amount in Row (11) 4.51% 14. Type of Reporting Person (See Instructions) IA 13G CUSIP No. 067806109 ITEM 1. (a) Name of Issuer: Barnes Group, Inc. (b) Address of Issuer's Principal Executive Offices: 123 MAIN ST BRISTOL, CONNECTICUT 06010 ITEM 2. (a) Name of Person Filing: Champlain Investment Partners, LLC (b) Address of Principal Business Office, or if None, Residence: 180 Battery St., Burlington, Vermont 05401 (c) Citizenship: Vermont (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 067806109 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SS.240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) [_] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [_] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [_] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a- 8). (e) [x] An investment adviser in accordance with ss.240.13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with ss.240.13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with ss.240.13d-1(b)(1)(ii)(G); (h) [_] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a- 3); (j) [_] Group, in accordance with ss.240.13d- 1(b)(1)(ii)(J). ITEM 4. OWNERSHIP. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 2282215 (b) Percent of class: 4.51% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 1738085 (ii) Shared power to vote or to direct the vote (iii) Sole power to dispose or to direct the disposition of 2282215 (iv) Shared power to dispose or to direct the disposition of INSTRUCTION. For computations regarding securities which represent a right to acquire an underlying security SEE ss.240.13d3(d)(1). ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. INSTRUCTION: Dissolution of a group requires a response to this item. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. If a parent holding company or Control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. If a group has filed this schedule pursuant to ss.240.13d- 1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to ss.240.13d-1(c) or ss.240.13d-1(d), attach an exhibit stating the identity of each member of the group. ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. ITEM 10. CERTIFICATIONS. (a) The following certification shall be included if the statement is filed pursuant to Rule 13d-1(b): "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect." (b) The following certification shall be included if the statement is filed pursuant to Rule 13d-1(c): "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect." SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: 2/13/2023 Signature: Matthew Garcia Name/Title: Matthew Garcia / Chief Compliance Officer The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7 for other parties for whom copies are to be sent. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)
Get the next $B alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$B

DatePrice TargetRatingAnalyst
4/18/2024$35.00 → $45.00Neutral → Buy
DA Davidson
10/11/2022Peer Perform
Wolfe Research
4/11/2022$42.00Overweight → Neutral
Alembic Global Advisors
More analyst ratings

$B
 Press Releases

Fastest customizable press release news feed in the world

See more

  • Therapeutic Goods Administration decides not to register lecanemab in Australia

    STOCKHOLM, Sweden, March 3, 2025 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ:BIOA) (STOCKHOLM: BIOA B) partner Eisai announced today that the Therapeutic Goods Administration (TGA) of Australia has declined the approval of lecanemab (generic name) as a treatment for early Alzheimer's disease (AD) (mild cognitive impairment due to AD and mild AD dementia). Eisai remains committed to ensuring eligible Australians with early Alzheimer's disease can access lecanemab and is exploring options to achieve this, including potentially seeking review by the Administrative Review Tribunal. In October 2024, the TGA made the decision not to register lecanemab in Australia for the treatment of patients

    $B
    $BIOA
    Metal Fabrications
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care

  • Miami International Holdings to List Bloomberg 500 Index Futures and Options on MIAX Exchanges

    MIAMI and PRINCETON, N.J., Jan. 29, 2025 /PRNewswire/ -- Miami International Holdings, Inc. (MIH), a technology-driven leader in building and operating regulated financial markets across multiple asset classes, today announced plans to list Bloomberg® 500 Index futures and options on its MIAX® exchanges in the second half of 2025, subject to various regulatory filings and approvals. MIAX Bloomberg 500 Index Futures will be listed on MIAX FuturesTM, pending certain filings with the Commodity Futures Trading Commission (CFTC). MIAX Bloomberg 500 Index Options will be listed on MIAX Options, pending certain filings with and subject to approval from the Securities and Exchange Commission (SEC).

    $B
    Metal Fabrications
    Industrials

  • Apollo Funds Complete Acquisition of Barnes Group

    Barnes Group Inc. (NYSE:B) ("Barnes" or "the Company"), a global provider of highly engineered products, differentiated industrial technologies and innovative solutions, and Apollo (NYSE:APO) today announced that funds managed by affiliates of Apollo (the "Apollo Funds") have completed the previously announced acquisition of Barnes in an all-cash transaction with a total enterprise value of approximately $3.6 billion. "We are pleased to announce the completion of our transaction with Apollo Funds, which opens the door to the next phase in Barnes' evolution," said Thomas J. Hook, President and Chief Executive Officer of Barnes. "Under Apollo Funds' ownership, we are well positioned to acce

    $APO
    $B
    Investment Managers
    Finance
    Metal Fabrications
    Industrials

$B
 Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$B
 Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$B
 Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$B
 SEC Filings

See more

$B
 Leadership Updates

Live Leadership Updates

See more

  • Guidewire Software Set to Join S&P MidCap 400; Arrowhead Pharmaceuticals to Join S&P SmallCap 600

    NEW YORK, Jan. 22, 2025 /PRNewswire/ -- Guidewire Software Inc. (NYSE:GWRE) will replace Arrowhead Pharmaceuticals Inc. (NASD: ARWR) in the S&P MidCap 400, and Arrowhead Pharmaceuticals will replace Barnes Group Inc. (NYSE:B) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, January 27. S&P 500 constituent Apollo Global Management Inc. (NYSE:APO) is acquiring Barnes Group in a deal expected to be completed soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector January 27, 2025 S&P MidCap 400 Addition Guidewi

    $APO
    $ARWR
    $B
    $GWRE
    Investment Managers
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care

  • Barnes Announces Update to Board of Directors

    Announces Planned Retirements of Chairman Thomas O. Barnes and Lead Independent Director Mylle H. Mangum, and appointment of Richard Hipple as Chair Elect Appoints Irenic Capital Management Co-Founder Adam Katz to the Board Enters into Cooperation Agreement with Irenic Capital Management Barnes Group Inc. (NYSE:B), a global provider of highly engineered products, differentiated industrial technologies, and innovative solutions, today announced the planned retirements of Chairman Thomas O. Barnes and Lead Independent Director Mylle H. Mangum, consistent with the Company's corporate governance retirement policy, effective at the Company's Annual Meeting of Stockholders in May 2024. Mr.

    $B
    $LMT
    $SPR
    Metal Fabrications
    Industrials
    Military/Government/Technical

  • Barnes Group Inc. Appoints Neal J. Keating to Board of Directors

    Barnes Group Inc. (NYSE:B), a global provider of highly engineered products, differentiated industrial technologies, and innovative solutions, today announced the appointment of Neal J. Keating to the Company's Board of Directors, effective February 9, 2023. Mr. Keating has also been appointed to the Company's Corporate Governance Committee. "We are pleased to welcome Neal to our Board of Directors," said Thomas O. Barnes, Chairman of the Board, Barnes Group Inc. "Neal brings extensive public company and board experience, and importantly he expands the Board's capabilities through his significant leadership experience in the aerospace industry, which aligns well with our growing Barnes Aer

    $B
    Metal Fabrications
    Industrials

$B
 Financials

Live finance-specific insights

See more

  • Barnes Group to Be Acquired by Apollo Funds for $3.6 Billion

    Barnes Shareholders to Receive $47.50 Per Share in Cash Barnes Group Inc. (NYSE:B) ("Barnes" or "the Company"), a global provider of highly engineered products, differentiated industrial technologies and innovative solutions, announced today that it has entered into a definitive agreement to be acquired by funds managed by affiliates of Apollo Global Management, Inc. (NYSE:APO) ("Apollo") (the "Apollo Funds") in an all-cash transaction that values Barnes at an enterprise value of approximately $3.6 billion. The agreement provides that Barnes shareholders will receive $47.50 per share in cash. The per share purchase price represents a premium of approximately 22% over Barnes' undisturbed c

    $APO
    $B
    Investment Managers
    Finance
    Metal Fabrications
    Industrials

  • Barnes Announces Third Quarter 2024 Earnings Conference Call and Webcast

    Barnes Group Inc. (NYSE:B) today announced it will release third quarter 2024 financial results on Friday, October 25, 2024, before the market opens. Barnes will also host a conference call which will begin at 8:30 a.m. (ET) on that day to discuss the results and the Company's outlook. The public may access the conference through a live audio webcast available on the Investor Relations section of the Barnes website at www.onebarnes.com. The conference is also available by direct dial at (888) 510-2379 in the U.S. or (646) 960-0691 outside of the U.S.; Conference ID 1137078. Supplemental materials will be posted to the Investor Relations section of the Company's website prior to the confere

    $B
    Metal Fabrications
    Industrials

  • Barnes Declares Quarterly Dividend

    The Board of Directors of Barnes Group Inc. (NYSE:B) has declared a quarterly cash dividend of sixteen cents ($0.16) per share. The dividend will be payable September 10, 2024, to shareholders of record at the close of business on August 22, 2024. Barnes and its predecessor companies have paid a cash dividend to stockholders on a continuous basis since 1934. About Barnes Barnes Group Inc. (NYSE:B) leverages world-class manufacturing capabilities and market-leading engineering to develop advanced processes, automation solutions, and applied technologies for industries ranging from aerospace and medical & personal care to mobility and packaging. With a celebrated legacy of pioneering ex

    $B
    Metal Fabrications
    Industrials

$B
 Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more